Real-world adherence trajectories to direct oral anticoagulants in naive patients with atrial fibrillation in Spain

Real-world adherence trajectories to direct oral anticoagulants in naive patients with atrial fibrillation in Spain

AimsThis study aimed to identify adherence trajectories and associated factors in atrial fibrillation patients who initiated direct oral anticoagulant (DOAC) therapy, using population-based data from the Catalonia and Valencia regions in Spain during a 2-year follow-up.Methods and ResultsGroup-based...

Full description

Saved in:

Bibliographic Details
Main Authors:	L. M. Leguízamo-Martínez, M. E. Ballarin, I. Hurtado, G. Sanfélix-Gimeno, F. Sánchez-Sáez, M. Sabaté
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-07-01
Series:	Frontiers in Pharmacology
Subjects:	direct oral anticoagulants (DOACs) adherence trajectories atrial fibrillation (AF) group-based trajectory modeling (GBTM) real-world data analysis
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1562620/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Inhospital outcomes of myocardial infarction in patients receiving direct oral anticoagulants
by: M. G. Chashchin, et al.
Published: (2023-11-01)

Direct oral anticoagulants (DOACs): From the laboratory point of view
by: Margetić Sandra, et al.
Published: (2022-12-01)

Hospital consumption of direct oral anticoagulants in regions of the Russian Federation in 2017–2022
by: A. V. Matveev, et al.
Published: (2024-01-01)

New prospects for assessing the hemostasis system in atrial fibrillation and left atrial appendage thrombosis
by: Z. A. Gebekova, et al.
Published: (2023-01-01)

Oral Anticoagulants in Chronic Thromboembolic Pulmonary Hypertension: Tradition or Innovation?
by: Domenico Laviola, et al.
Published: (2025-07-01)

The impact of long-term trends in continuity of care on the medical expenses of hypertensive patients: based on group-based trajectory model
by: Yanqiu Du, et al.
Published: (2025-07-01)

Balancing the risks: continuous vs. interrupted anticoagulation during TAVI – what does the evidence say?
by: Ravi Patel, et al.
Published: (2025-01-01)

Direct oral anticoagulants (DOACs) for postoperative venous thromboembolism prophylaxis in patients with gynecologic malignancies: A quality mini-review
by: Peter W. Ketch, et al.
Published: (2024-12-01)

Improvement of Oral Anticoagulant Prescription and Long‐Term Clinical Outcomes of Patients With Atrial Fibrillation After Implementation of a Clinical Decision Support System in Outpatient Practice
by: Po‐Tseng Lee, et al.
Published: (2025-08-01)

Modern possibilities and prospects in evaluating the anticoagulant effect of direct oral anticoagulants
by: A. I. Mironova, et al.
Published: (2022-06-01)

Real world data on characteristics and management of community patients receiving anticoagulation therapy who presented with acute bleeding to the emergency department at a regional Australian hospital: A prospective observational study.
by: Fayez Hanna, et al.
Published: (2021-02-01)

Polysocial risk factors and trajectories of antenatal moderate-to-severe depressive symptoms: a retrospective cohort study in Shenzhen, China
by: Jintao Xiong, et al.
Published: (2025-07-01)

Association between three-timepoint maternal blood pressure trajectories during pregnancy and low birth weight: a longitudinal study based on NHANES 2005–2006
by: Huiqiang Liu, et al.
Published: (2025-06-01)

Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): statistical analysis plan for a randomised controlled trial
by: Norin Ahmed, et al.
Published: (2025-02-01)

Untangling areas of improvement in secondary prevention of ischemic stroke in patients with atrial fibrillation
by: F Sánchez-Sáez, et al.
Published: (2024-12-01)

Cerebellar hemorrhage in patients treated with edoxaban for portal vein thrombosis after hepatobiliary surgery: a report of two cases
by: Hiroya Iida, et al.
Published: (2020-12-01)

Development and Validation of an HPLC-MS/MS Method for Quantification of Apixaban in Human Plasma
by: U. D. Filonova, et al.
Published: (2024-03-01)

Predictors and Outcomes of Inappropriate Dosing of Direct Oral Anticoagulants in Patients Receiving Transcatheter Aortic Valve Implantation
by: Danial Amoey, et al.
Published: (2024-11-01)

The dose-dependent antiangiogenic potential of apixaban: an experimental outlook
by: Özgür Akkaya, et al.
Published: (2022-08-01)

From the INVICTUS Trial to Current Considerations: It’s Not Time to Retire Vitamin K Inhibitors Yet!
by: Akshyaya Pradhan, et al.
Published: (2024-10-01)

Esophagitis Dissecans Superficialis in a Frail Older Patient: Questioning Its Benign Nature
by: Donna Erven, et al.
Published: (2025-08-01)

To clot, or not to clot – Antithrombotic therapy is the question
by: E. Osuch, et al.
Published: (2019-07-01)

Evaluation of Drug–Drug Interactions Between Clarithromycin and Direct Oral Anticoagulants Using Physiologically Based Pharmacokinetic Models
by: Zhuan Yang, et al.
Published: (2024-11-01)

Direct-acting oral anticoagulant removal by intraoperative hemoadsorption in CABG and/or single valve surgery: interim analysis of the International Safe and Timely Antithrombotic Removal (STAR) registry
by: Michael Schmoeckel, et al.
Published: (2025-01-01)

Cost–effectiveness and budget impact analysis of switching from apixaban to rivaroxaban treatment among patients with nonvalvular atrial fibrillation in a German healthcare setting
by: Rupesh Subash, et al.
Published: (2025-05-01)

FOUR–DIMENSIONAL BRUSSELATOR MODEL WITH PERIODICAL SOLUTION
by: Odiljon S. Akhmedov, et al.
Published: (2020-07-01)

GoalNet: Goal Areas Oriented Pedestrian Trajectory Prediction
by: Amar Fadillah, et al.
Published: (2025-01-01)

ANALYTICS AND DATA SCIENCE APPLIED TO THE TRAJECTORY OUTLIER DETECTION
by: Alexis J. LOPEZ, et al.
Published: (2020-06-01)

Inappropriate dosing of direct oral anticoagulants: findings from a clinical vignette study and physician survey
by: Ahmet Fuat, et al.
Published: (2023-12-01)

Dummy trajectory privacy protection scheme for trajectory publishing based on the spatiotemporal correlation
by: Kai-yue LEI, et al.
Published: (2016-12-01)

Apixaban failure in a post-bariatric surgery female patient with thoracic aortic thrombus secondary to COVID-19
by: Joshua Hermiz, et al.
Published: (2025-03-01)

Bleeding Associated With Antiarrhythmic Drugs in Patients With Atrial Fibrillation Using Direct Oral Anticoagulants: A Nationwide Population Cohort Study
by: Victor Chien‐Chia Wu, et al.
Published: (2024-11-01)

Evaluating Major Bleeding Risks with Concomitant Use of Direct Oral Anticoagulants and Selective Serotonin Reuptake Inhibitors in Nonvalvular Atrial Fibrillation Patients
by: Shu-Yu Yao, et al.
Published: (2025-03-01)

Uncertain trajectory privacy-preserving method of moving object
by: Shuang WANG, et al.
Published: (2015-11-01)

Resolution of the International meeting of experts on the exchange of scientific experience in the use of anticoagulants in patients with COVID-19
by: S. N. Avdeev, et al.
Published: (2020-09-01)

Direct Oral Anticoagulants Compared to Warfarin in Patients with Intermediate‐ to High‐Risk Pulmonary Embolism: A Systematic Review and Meta‐Analysis
by: Mohamed Nabil Elshafei, et al.
Published: (2025-06-01)

Quantitative Methods for Evaluating Long-Term Career Attitudes of the Subjects of Modern Society («Model of the Life Trajectory»)
by: P. V. Konyukhovsky, et al.
Published: (2024-02-01)

Changing the load of a arrow crane while carrying out loading and unloading works
by: Sladkova L.A, et al.
Published: (2020-06-01)

DIRECT ORAL ANTICOAGULANTS
by: I. Tzoran, et al.
Published: (2016-06-01)

Changes in the system of physiological anticoagulants at arterial hypertension in children
by: V. V. Dolgikh, et al.
Published: (2013-11-01)